EUVIMEDEUVIMED entdecken
Crossref

Uric acid to high density lipoprotein-cholesterol ratio as a potential biomarker of comorbidities in youth with obesity

Procolo Di Bonito, Giuseppina Rosaria Umano, Maria Rosaria Licenziati, Domenico Corica, Małgorzata Gabriela Wasniewska, Anita Morandi, Claudio Maffeis, Maria Felicia Faienza, Enza Mozzillo, Valeria Calcaterra, Francesca Franco, Giulio Maltoni und 3 weitere

Nutrition, Metabolism and Cardiovascular Diseases · 2026

DOI: 10.1016/j.numecd.2026.104847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Procolo Di Bonito und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, "S. Maria delle Grazie" Hospital, Pozzuoli, Italy. Hauptthemen laut MEDLINE: Uric Acid, Pediatric Obesity, Cholesterol, HDL, Metabolic Syndrome. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: The uric acid to high-density lipoprotein-cholesterol ratio (UHR) has been associated with type 2 diabetes or hepatic steatosis in adults, while pediatric evidence is poor. We aimed to evaluate the association between UHR and several obesity-related comorbidities in youths with overweight or obesity (OW/OB). METHODS AND RESULTS: 1215 youths of the CARITALY study were enrolled. Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) were assessed by standard methods. The homeostasis model assessment of insulin resistance (HOMA-IR) and the whole-body insulin sensitivity index (WBISI) were calculated. A continuous cardiometabolic risk score (cCMR) was calculated. Metabolic-associated steatotic liver disease (MASLD) was defined by a standard method. Mild reduced-estimated glomerular filtration rate (MReGFR) was defined by eGFR value > 60 < 90 ml/min/1.73 m2 White blood cell count (WBCc) was obtained. UHR was stratified into quartiles. Youths in the top UHR quartile showed a higher odds ratio (OR)(95%CI) of MReGFR: 2.03 (1.31-3.13) and cCMR: 2915 (1.60-4.24) vs the first quartile. Youths in the third UHR quartile showed significantly higher ORs of IFG 2.00 (1.01-3.94), IGT: 2.64 (1.37-5.10), HOMA-IR: 1.64 (1.17-2.29), and high WBCc: 2.49 (1.64-3.77), whereas youths yet in the second quartile showed significantly higher OR of low WBISI: 1.60 (1.04-2.50) and MASLD: 1.61 (1.13-2.28) vs the first quartile. CONCLUSIONS: UHR was associated with disrupted glucose homeostasis, high cardiometabolic risk, MASLD, reduced glomerular filtration, and low-grade inflammation in youths with OW/OB. UHR is a promising biomarker for detecting obesity-related comorbidities in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uric AcidPediatric ObesityCholesterol, HDLMetabolic SyndromeHumansFemaleMaleBiomarkersAdolescentChildRisk AssessmentPredictive Value of TestsCross-Sectional StudiesComorbidityItalyAge FactorsCardiometabolic Risk FactorsGlomerular Filtration RateBlood GlucoseInsulin Resistance

Stichwörter der Autor:innen

Cardiometabolic riskMetabolic-associated steatotic liver diseasePediatric obesityPrediabetesReduced glomerular filtration

Substanzen

BiomarkersUric AcidCholesterol, HDLBlood Glucose

Autor:innen und Institutionen

  • Department of Internal Medicine, "S. Maria delle Grazie" Hospital, Pozzuoli, Italy.
  • Department of the Woman, the Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Neuro-Endocrine Diseases and Obesity Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
  • Department of Human Pathology of Adulthood and Childhood "G. Barresi", Pediatric Unit, University of Messina, Messina, Italy.
  • Department of Surgery, Dentistry, Pediatrics and Gynecology, Section of Pediatric Diabetes and Metabolism, University and University Hospital of Verona, Verona, Italy.
  • Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "A. Moro", Bari, Italy.

Zitieren

APA

Di Bonito, P., Umano, G. R., Licenziati, M. R., Corica, D., Wasniewska, M. G., Morandi, A., Maffeis, C., Faienza, M. F., Mozzillo, E., Calcaterra, V., Franco, F., Maltoni, G., Del Giudice, E. M., Di Sessa, A., & Valerio, G. (2026). Uric acid to high density lipoprotein-cholesterol ratio as a potential biomarker of comorbidities in youth with obesity. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2026.104847

Vancouver

Di Bonito P, Umano GR, Licenziati MR, Corica D, Wasniewska MG, Morandi A, et al. Uric acid to high density lipoprotein-cholesterol ratio as a potential biomarker of comorbidities in youth with obesity. Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2026.104847

BibTeX
@article{DiBonito2026,
  author = {Di Bonito, Procolo and Umano, Giuseppina Rosaria and Licenziati, Maria Rosaria and Corica, Domenico and Wasniewska, Małgorzata Gabriela and Morandi, Anita and Maffeis, Claudio and Faienza, Maria Felicia and Mozzillo, Enza and Calcaterra, Valeria and Franco, Francesca and Maltoni, Giulio and Del Giudice, Emanuele Miraglia and Di Sessa, Anna and Valerio, Giuliana},
  title = {Uric acid to high density lipoprotein-cholesterol ratio as a potential biomarker of comorbidities in youth with obesity},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.numecd.2026.104847}
}
Kostenlos starten →